Paper38904014
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer.
Fontana F and 3 others. Int J Biol Sci, 2024. Cited by 246 papers, by iCite.
Cite this record
ConductScience Library. The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. Papers, record 38904014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38904014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Glucose | Major topic |
| Signal Transduction | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Humans | |
| Animals | |
| Glycolysis |
Source PubMed
References172
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21211574 | Respiratory competent mitochondria in human ovarian and peritoneal cancer. | Mitochondrion | 2011 | https://conductscience.org/library/papers/21211574 | PubMed |
| 2 | 20005212 | Identification of small molecule inhibitors of pyruvate kinase M2. | Biochem Pharmacol | 2010 | https://conductscience.org/library/papers/20005212 | PubMed |
| 3 | 16007182 | PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. | Oncogene | 2005 | https://conductscience.org/library/papers/16007182 | PubMed |
| 4 | 35847880 | Extracellular Hsp90α Supports the ePKM2-GRP78-AKT Axis to Promote Tumor Metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/35847880 | PubMed |
| 5 | 31912488 | PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer. | Dev Growth Differ | 2020 | https://conductscience.org/library/papers/31912488 | PubMed |
| 6 | 25537655 | ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. | Curr Drug Targets | 2015 | https://conductscience.org/library/papers/25537655 | PubMed |
| 7 | 10749120 | Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. | Cancer Res | 2000 | https://conductscience.org/library/papers/10749120 | PubMed |
| 8 | 37820006 | Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37820006 | PubMed |
| 9 | 15241468 | Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. | EMBO J | 2004 | https://conductscience.org/library/papers/15241468 | PubMed |
| 10 | 31426130 | Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer. | Cancer Med | 2019 | https://conductscience.org/library/papers/31426130 | PubMed |
| 11 | 25956709 | Direct and indirect targeting of MYC to treat acute myeloid leukemia. | Cancer Chemother Pharmacol | 2015 | https://conductscience.org/library/papers/25956709 | PubMed |
| 12 | 30266938 | Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis. | Sci Rep | 2018 | https://conductscience.org/library/papers/30266938 | PubMed |
| 13 | 35953860 | Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells. | J Ovarian Res | 2022 | https://conductscience.org/library/papers/35953860 | PubMed |
| 14 | 32843638 | The updated landscape of tumor microenvironment and drug repurposing. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32843638 | PubMed |
| 15 | 29185365 | Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform. | J Enzyme Inhib Med Chem | 2018 | https://conductscience.org/library/papers/29185365 | PubMed |
| 16 | 26097593 | HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26097593 | PubMed |
| 17 | 24981175 | Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis. | Mol Cell | 2014 | https://conductscience.org/library/papers/24981175 | PubMed |
| 18 | 2157546 | The impairment of respiration by glycolysis in the Lewis lung carcinoma. | Cancer Lett | 1990 | https://conductscience.org/library/papers/2157546 | PubMed |
| 19 | 25277420 | The Warburg effect: evolving interpretations of an established concept. | Free Radic Biol Med | 2015 | https://conductscience.org/library/papers/25277420 | PubMed |
| 20 | 34286881 | Reactive oxygen species in cancer: Current findings and future directions. | Cancer Sci | 2021 | https://conductscience.org/library/papers/34286881 | PubMed |
Cited by188
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978971 | Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42978971 | PubMed |
| 42910561 | Driver Gene Mutations Reprogram Lipid Metabolism in Non-Small Cell Lung Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42910561 | PubMed |
| 42908740 | PDGF-BB secreted by OTSCC orchestrates CAF-driven tumor progression through regulating the LINC00886/hsa-miR-15b-5p/AKT axis. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42908740 | PubMed |
| 42882913 | PODXL2 Expression Is Associated with Inferior Survival, Adverse-Risk Features, and Distinct Transcriptional Programs in Acute Myeloid Leukemia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882913 | PubMed |
| 42882424 | Spatial Architecture of GLUT1 and Glycolytic Complexes in Breast Cancer. | Cells | 2026 | https://conductscience.org/library/papers/42882424 | PubMed |
| 42877086 | Biomaterial-driven remove-remodel-repair (3R) strategy for full-cycle gastric cancer management: bibliometric mapping, preclinical evidence, and a translational roadmap. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42877086 | PubMed |
| 42836789 | Quercetin in Myocardial Ischemia-Reperfusion Injury: Mechanistic Evidence, Cardioprotective Effects, and Translational Challenges. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42836789 | PubMed |
| 42819642 | Research advances in red ginseng polysaccharides: preparation, structural characteristics and immunomodulatory effect. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42819642 | PubMed |
| 42807855 | Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807855 | PubMed |
| 42799075 | Traditional Chinese medicine reprograms the tumor microenvironment to overcome EGFR-TKI resistance: mechanisms and therapeutic perspectives. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42799075 | PubMed |
| 42792873 | Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792873 | PubMed |
| 42780483 | Targeting the PI3K/Akt Signaling Pathway: A Promising Therapeutic Strategy to Reduce Cancer Mortality and Overcome Chemoresistance. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42780483 | PubMed |
| 42778549 | Heterogeneity in cancer: molecular mechanisms and therapeutic strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42778549 | PubMed |
| 42762350 | Neurexophilin 4 facilitates the malignant progression of kidney renal clear cell carcinoma by regulating PI3K/AKT-mediated glycolysis. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42762350 | PubMed |
| 42757469 | FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis. | Oncol Rep | 2026 | https://conductscience.org/library/papers/42757469 | PubMed |
| 42750747 | Unraveling the pleiotropic roles of the mTOR-glycolytic axis in ulcerative colitis: from immunometabolic dysregulation to mucosal barrier remodeling. | Front Immunol | 2026 | https://conductscience.org/library/papers/42750747 | PubMed |
| 42747630 | Role of glycosylated small noncoding RNAs in tumor: mechanism, function and clinical significance. | Glycoconj J | 2026 | https://conductscience.org/library/papers/42747630 | PubMed |
| 42738319 | PIK3CA in Cancer: Structure, Biology, Alterations, and Actionability. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738319 | PubMed |
| 42724896 | Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724896 | PubMed |
| 42724826 | Hypoxia-inducible factor-1α promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724826 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| HK2 | 3099 | PubTator's text mining | https://conductscience.org/library/genes/3099 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PKM | 5315 | PubTator's text mining | https://conductscience.org/library/genes/5315 | NCBI Gene |
| SLC2A1 | 6513 | PubTator's text mining | https://conductscience.org/library/genes/6513 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38904014
GET https://conductscience.org/api/papers/v1/38904014/references?page=2